Harte-Hanks Stockholders Approve Key Governance Decisions

Harte-Hanks ( (HHS) ) has shared an announcement.

At the Harte Hanks 2025 Annual Meeting of Stockholders held on May 22, 2025, stockholders voted on key governance and operational matters. Four board nominees were elected to serve until the 2026 annual meeting, and the compensation of named executive officers was approved on a non-binding advisory basis. Additionally, the selection of Wolf & Company P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.

The most recent analyst rating on (HHS) stock is a Buy with a $17.50 price target. To see the full list of analyst forecasts on Harte-Hanks stock, see the HHS Stock Forecast page.

Spark’s Take on HHS Stock

According to Spark, TipRanks’ AI Analyst, HHS is a Neutral.

Harte-Hanks’ overall stock score reflects significant financial challenges and weak technical indicators. The company struggles with declining revenues, persistent losses, and negative cash flow. Technical analysis further indicates a bearish trend. With no earnings call data or notable corporate events to provide additional insights, the stock score remains low, emphasizing the need for strategic improvements in financial performance and investor returns.

To see Spark’s full report on HHS stock, click here.

More about Harte-Hanks

Harte Hanks, Inc. operates in the marketing services industry, providing a range of customer engagement solutions including data-driven marketing and targeted communications. The company focuses on enhancing customer interactions and improving brand loyalty for its clients.

Average Trading Volume: 19,334

Technical Sentiment Signal: Sell

Current Market Cap: $33.56M

For detailed information about HHS stock, go to TipRanks’ Stock Analysis page.